AGs' Entrance Complicates CSR Case; Administration Still Considers Ending Payments

By Amy Lotven / August 3, 2017 at 2:37 PM
Legal experts appear to agree that while this week's federal appeals court decision allowing Democratic attorneys general to intervene in House v. Price may not fully curtail the president's ability to end the Affordable Care Act's cost-sharing reduction payments, it complicates the White House's ability to do so unilaterally. White House budget chief Mick Mulvaney said Wednesday (Aug. 2) that pulling the payments is still under consideration. The administration has said from the very beginning that the decision on...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.